| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―09 |
Statement of Retraction: Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients |
|
| 2 |
[GO] |
2024―Aug―07 |
COVID-19: did the masks work? |
Roy D Sleator, Niall Smith |
| 3 |
[GO] |
2024―Jul―04 |
Letter to the editor: before molecules are claimed as biomarkers of COVID-19, their criteria must be met |
Josef Finsterer |
| 4 |
[GO] |
2024―Jun―24 |
Letter in reply: before biomolecules are claimed as biomarkers of COVID-19, their criteria must be met |
Murat Karamese |
| 5 |
[GO] |
2024―Jun―24 |
Clostridioides difficile
infection epidemiology during the COVID-19 pandemic in Greece |
Theodoros Karampatakis, Eleni Kandilioti, Helen Katsifa, Anna Nikopoulou, Celine Harmanus, Katerina Tsergouli, Ed Kuijper, Melina Kachrimanidou |
| 6 |
[GO] |
2024―May―31 |
Severe mold fungal infections in critically ill patients with COVID-19 |
Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn Blot |
| 7 |
[GO] |
2024―May―23 |
Online dashboards for SARS-CoV-2 wastewater-based epidemiology |
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi |
| 8 |
[GO] |
2024―Apr―17 |
JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants |
Soumya Basu, Titirsha Kayal, Ponoop Prasad Patro, Amit Patnaik |
| 9 |
[GO] |
2024―Jan―31 |
Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis |
Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza |
| 10 |
[GO] |
2024―Jan―31 |
Triple in silico targeting of IMPDH enzyme and RNA-dependent RNA polymerase of both SARS-CoV-2 and Rhizopus oryzae |
Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary |
| 11 |
[GO] |
2023―Nov―01 |
Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients |
Murat Karamese, Abdullah Gumus, Eray Atalay, Emin E Tutuncu |
| 12 |
[GO] |
2023―Oct―20 |
Plain language summary: Did the COVID-19 pandemic change the resistance to current antifungal medicines? |
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira |
| 13 |
[GO] |
2023―Oct―18 |
Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico |
Jorge A Rangel-Méndez, Luciola Jaimes-Gurrusquieta, Juan F Sánchez-Cruz, Ma I Zarate-Murillo, Jessica Domínguez-Méndez, Hugo A Laviada-Molina, Daniel Casares-González, Elideth M Flores-Flores |
| 14 |
[GO] |
2023―Sep―26 |
Has coronavirus disease 2019 changed clinical microbiology laboratories forever? |
Joseph M Blondeau, Jennifer Coetzee |
| 15 |
[GO] |
2023―Sep―05 |
Pandemic predictions and precautionary preparations: lessons from history |
Thomas H Pennington |
| 16 |
[GO] |
2023―Jul―14 |
Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals |
Maria LS Pereira, Davi AC Mothé, Kézia S Pinheiro, Sarah S Gonçalves, Kênia V Santos |
| 17 |
[GO] |
2023―Mar―14 |
Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study |
Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, Cansu Belge, Ridvan Karahasanoglu, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Nihal Yildirim, Bedriye Kar, Mediha Bozkurt, Kubra Karanalbant, Burcu Atasoy, Hindirin Takak, Serap Simsek-Yavuz, Rustu Turkay, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu |
| 18 |
[GO] |
2023―Jan―17 |
Mucormycosis in the COVID-19 scenario beyond hospitalized patients |
Alexandro Bonifaz, Andrés Tirado-Sánchez, Javier Araiza, María Luisa Hernández-Medel |
| 19 |
[GO] |
2022―Oct―06 |
Acinetobacter baumannii infections resistant to treatment: warning signs from the COVID-19 pandemic |
Ryan C Ellis, Elena K Roberts, Jennifer T Grier, Steven E Fiester |
| 20 |
[GO] |
2022―Sep―28 |
Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data |
Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Filiz Pehlivanoglu, Gonul Sengoz |
| 21 |
[GO] |
2022―Sep―16 |
Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21 |
Lucyana LC Coutinho, Caroline N Oliveira, Polianna LMM Albuquerque, Sandra MB Mota, Gdayllon C Meneses, Alice MC Martins, Geraldo BS Junior, Marco AF Clementino, Rafhaella NDG Gondim, Alexandre Havt, Luciano PG Cavalcanti, Juliana NU Yaochite |
| 22 |
[GO] |
2022―Sep―16 |
Comment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’ |
Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García, Javier Mancilla-Galindo |
| 23 |
[GO] |
2022―Aug―04 |
Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection |
Atalay Eray, Karamese Murat, Gumus Abdullah, Kahraman Ihsan, Kelesoglu Royca, Ozgur Didem, Tutuncu E Ediz |
| 24 |
[GO] |
2022―Jul―28 |
Role of the PD-1 and PD-L1 axis in COVID-19 |
Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry |
| 25 |
[GO] |
2022―Jul―28 |
First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria |
Denis Niyazi, Borislava Toncheva, Tsvetan Tonchev, Deyan Dzhenkov, Kalin Kalchev, Temenuga Stoeva |
| 26 |
[GO] |
2022―Jul―28 |
Coinfection with Strongyloides and Ascaris in a COVID-19-positive male presenting with acute abdomen: a case report |
Sweta Singh, Uday S Singh |
| 27 |
[GO] |
2022―Jul―28 |
SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure |
Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian |
| 28 |
[GO] |
2022―Jul―26 |
G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19 |
Abir Mondal, Soumyadeep Mukherjee, Waseem Dar, Prince Upadhyay, Anand Ranganathan, Soumya Pati, Shailja Singh |
| 29 |
[GO] |
2022―Jul―26 |
Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha |
Tjaša Ž Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, Barbara J Bizjan, Samo Jeverica, Mateja Ravnik, Mitja Rak, Mateja Borinc, Maja Rupnik, Tadej Battelino, Marko Pokorn, Jernej Kovač |
| 30 |
[GO] |
2022―May―05 |
Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? |
Sheila Santa, Derek A Doku, Charles O Olwal, Charles A Brown, Emmanuel A Tagoe, Osbourne Quaye |
| 31 |
[GO] |
2022―May―05 |
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective |
Abdo A Elfiky |
| 32 |
[GO] |
2022―Apr―25 |
Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19 |
Malihe Naderi, Seyed Amir Soltani, Akram Taheri Rad, Zahra Mehrbakhsh, Sina Sodagar, Alireza Tahamtan, Seyedeh Sedigheh Hosseini |
| 33 |
[GO] |
2022―Apr―20 |
Clostridioides difficile co-infection in patients with COVID-19 |
Roman Maslennikov, Vladimir Ivashkin, Anna Ufimtseva, Elena Poluektova, Anatoly Ulyanin |
| 34 |
[GO] |
2022―Apr―01 |
Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children |
Danilo Buonsenso, Ferran Espuny Pujol, Daniel Munblit, Davide Pata, Sammie McFarland, Frances K Simpson |
| 35 |
[GO] |
2022―Mar―30 |
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2 |
Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, Sundararaj S Jeremiah, Michiharu Kudo, Akihide Ryo |
| 36 |
[GO] |
2022―Mar―14 |
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis |
Kevin Bouiller, Nathan Peiffer-Smadja, Muge Cevik, Katharina Last, Ivana A Antunović, Anja Šterbenc, Maria J Lopes, Aleksandra Barac, Valentijn Schweitzer, Sarah Dellière |
| 37 |
[GO] |
2022―Mar―14 |
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest |
Abdullah Al Saba, Maisha Adiba, Sajib Chakraborty, AHM Nurun Nabi |
| 38 |
[GO] |
2022―Feb―24 |
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic |
Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki |
| 39 |
[GO] |
2022―Feb―15 |
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic |
Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall |
| 40 |
[GO] |
2022―Feb―09 |
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients |
Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody |
| 41 |
[GO] |
2022―Jan―19 |
Scrub typhus in two COVID-19 patients: a diagnostic dilemma |
Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, Ridhima Bhatia, Ajisha Aravindan, Naveet Wig, Randeep Guleria, Rama Chaudhry |
| 42 |
[GO] |
2022―Jan―19 |
Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
Michael Frank |
| 43 |
[GO] |
2021―Dec―17 |
Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 |
Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, Craig J Tilley, Simran Kang, Amrita Rai, She Lok, Alison McMillan |
| 44 |
[GO] |
2021―Dec―17 |
Inflammation at the crossroads of Helicobacter pylori and COVID-19 |
Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas |
| 45 |
[GO] |
2021―Nov―23 |
Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients |
Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, Osman Faruk Bayramlar, Ahmet Buyukyazgan, Ayse Ruhkar Kurt Cinar, Hatice Balli, Yesim Kurekci, Filiz Pehlivanoglu, Gonul Sengoz |
| 46 |
[GO] |
2021―Nov―23 |
Drug-based therapeutic strategies for COVID-19-infected patients and their challenges |
Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, Rahil Fazlinejad, Soliman Mohammadi-Samani, Negar Firouzabadi, Majid Hosseini, Fatemeh Farjadian |
| 47 |
[GO] |
2021―Nov―11 |
Current status of therapeutic approaches and vaccines for SARS-CoV-2 |
Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees |
| 48 |
[GO] |
2021―Nov―10 |
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV |
Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult |
| 49 |
[GO] |
2021―Oct―25 |
Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection |
Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, Chern E Oon, Pegah Moradi Khaniabadi, Syed Haroon Khalid, Ikram Ullah Khan |
| 50 |
[GO] |
2021―Oct―22 |
A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India |
Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya |
| 51 |
[GO] |
2021―Oct―07 |
Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey |
Murat Karamese, Didem Ozgur, Emin E Tutuncu |
| 52 |
[GO] |
2021―Sep―01 |
Coronaviruses construct an interconnection way with ERAD and autophagy |
Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour |
| 53 |
[GO] |
2021―Sep―01 |
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses |
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi |
| 54 |
[GO] |
2021―Jul―28 |
Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study |
Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok |
| 55 |
[GO] |
2021―Jul―28 |
Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? |
Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi |
| 56 |
[GO] |
2021―Jul―05 |
Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR |
Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, Saliha Kazci, Mursel Karadavut, Abdullah Gumus, Gozde Apaydin, Necati Mumcu, Onur Coruh, Emin E Tutuncu |
| 57 |
[GO] |
2021―Jun―24 |
Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 |
Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni |
| 58 |
[GO] |
2021―Jun―04 |
Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau |
Joseph Blondeau |
| 59 |
[GO] |
2021―May―17 |
Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez |
Peter Hotez |
| 60 |
[GO] |
2021―May―11 |
Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response |
Xin Chen, Mingli Gu, Tengda Li, Yi Sun |
| 61 |
[GO] |
2021―May―07 |
Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes |
Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris |
| 62 |
[GO] |
2021―Apr―13 |
Herd immunity: could it bring the COVID-19 pandemic to an end? |
Thomas Hugh Pennington |
| 63 |
[GO] |
2021―Apr―13 |
The interplay of SARS-CoV-2 and Clostridioides difficile infection |
Sahil Khanna, Colleen S Kraft |
| 64 |
[GO] |
2021―Mar―12 |
COVID-19 pneumonia: do not leave the corticosteroids behind! |
Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa |
| 65 |
[GO] |
2021―Feb―11 |
Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment |
Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos |
| 66 |
[GO] |
2021―Jan―25 |
COVID-19: it is all about sepsis |
Jean-Louis Vincent |
| 67 |
[GO] |
2021―Jan―19 |
Review of the use of nasal and oral antiseptics during a global pandemic |
Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar |
| 68 |
[GO] |
2021―Jan―18 |
The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 |
Mayra Cuéllar-Cruz |
| 69 |
[GO] |
2021―Jan―06 |
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients |
Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, Abolghasem Jouyban, Susan CJ Sumner |
| 70 |
[GO] |
2021―Jan―06 |
Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? |
Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye |
| 71 |
[GO] |
2020―Dec―22 |
COVID-19: mask efficacy is dependent on both fabric and fit |
Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, Liam Lewis, Niall Smith, Roy D Sleator |
| 72 |
[GO] |
2020―Nov―24 |
Chloroquine/hydroxycloroquine and COVID-19: need to know more about |
Antonio Cassone, Licia Iacoviello, Roberto Cauda |
| 73 |
[GO] |
2020―Nov―20 |
The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic |
Lígia N de M Ribeiro, Belchiolina B Fonseca |
| 74 |
[GO] |
2020―Nov―12 |
Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints |
Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, Meenakshi Ahluwalia, Yasmeen Jilani, Alka Chaubey, Madhuri Hegde, Vamsi Kota, Amyn Rojiani, Ravindra Kolhe |
| 75 |
[GO] |
2020―Nov―06 |
Clinical microbiology laboratories and COVID-19: the calm before the storm |
Joseph M Blondeau |
| 76 |
[GO] |
2020―Nov―06 |
Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation |
Michael B Yakass, Osbourne Quaye, Bryan J Woodward |
| 77 |
[GO] |
2020―Nov―03 |
Coronavirus pandemic: treatment and future prevention |
Kenneth Lundstrom |
| 78 |
[GO] |
2020―Oct―21 |
Systemic mycoses: a potential alert for complications in COVID-19 patients |
Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases |
| 79 |
[GO] |
2020―Oct―21 |
Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 80 |
[GO] |
2020―Sep―21 |
Potential alteration of COVID-19 by beta-mercaptoethanol |
Robert E Click |
| 81 |
[GO] |
2020―Sep―03 |
SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall |
Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris |
| 82 |
[GO] |
2020―Aug―27 |
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) |
Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh |
| 83 |
[GO] |
2020―Aug―26 |
Phages in the fight against COVID-19? |
Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski |
| 84 |
[GO] |
2020―Aug―14 |
Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients |
Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, Peng Liu, Quan-Xu Ge, Ming-Yi Wang |
| 85 |
[GO] |
2020―Jul―17 |
COVID-19: in the absence of vaccination - ‘mask-the-nation’ |
Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith |
| 86 |
[GO] |
2020―Jul―14 |
N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 |
Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester |
| 87 |
[GO] |
2020―Jul―08 |
The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review |
Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani |
| 88 |
[GO] |
2020―Jun―11 |
Focus on a 2019-novel coronavirus (SARS-CoV-2) |
Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang |
